Enhancing chemotherapy efficacy by reprogramming the senescence-associated secretory phenotype of prostate tumors: A way to reactivate the antitumor immunity
Oncoimmunology. 2015 Jan 22;4(3):e994380.
doi: 10.4161/2162402X.2014.994380.
eCollection 2015 Mar.
1 Institute of Oncology Research (IOR) and Oncology Institute of Southern Switzerland (IOSI) ; Bellinzona, Switzerland.
2 Institute of Oncology Research (IOR) and Oncology Institute of Southern Switzerland (IOSI) ; Bellinzona, Switzerland ; Faculty of Biology and Medicine; University of Lausanne ; Lausanne, Switzerland.